Cardiovascular residual risk: what are the markers?

28 August 2017 (13:07 - 13:17)

Organised by:

Video

Sign in to view the resources

Slides

About the speaker

Professor Wolfgang Koenig

Technical University of Munich, Munich (Germany)

6 More presentations in this session

Presentation thumbnail

Welcome - Atherosclerosis and secondary cardiovascular disease prevention: inflammation and LDL-cholesterol.

Professor T. Luescher (London, GB)

Presentation thumbnail

Atherosclerosis and the cardiovascular continuum.

Professor P. Libby (Boston, US)

Presentation thumbnail

What are the unmet medical needs in secondary cardiovascular disease prevention?

Professor P. Steg (Paris, FR)

Presentation thumbnail

Secondary cardiovascular disease prevention: what have we learnt from recent clinical trials?

Doctor P. Ridker (Boston, US)

Presentation thumbnail

Audience Q&A and panel discussion - Atherosclerosis and secondary cardiovascular disease prevention: inflammation and LDL-cholesterol.

Professor P. Libby (Boston, US)

Access the full session

Session thumbnail

Atherosclerosis and secondary cardiovascular disease prevention: inflammation and low density lipoprotein (LDL)-cholesterol

The Event

ESC Congress 2017

28 August 2017 13:07 CET

You may be interested in

Congress Presentation

Residual cardiovascular risk of patients with dyslipidemia receiving multifactorial cardiovascular prevention therapy

27 August 2021

Webinar

ACVC Biomarker Talk Series - Screening the general population - a role for cardiac biomarkers?

13 July 2022

Congress Session

Optimising cardiovascular risk prediction and management in patients with renal disease

4 April 2025

Congress Presentation

The 5 key take home messages

31 August 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources